1412892-09-1

1412892-09-1 structure

Name: Naptumomab
Chemical Name: Naptumomab
CAS Number: 1412892-09-1
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Cancer
Create Date: 2022-08-15 19:24:11
Modify Date: 2025-08-25 12:14:33
Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid tumors such as renal cell carcinoma[1][2].

Name	Naptumomab

Description	Naptumomab, a tumor targeting superantigen (TTS), is a fusion protein containing. Naptumomab stimulates the immune system to identify and kill tumour cells. Naptumomab can be used for the research of refractory solid tumors such as renal cell carcinoma[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
References	[1]. Matthew K Robinson, et al. Naptumomab estafenatox: a new immunoconjugate. Expert Opin Biol Ther. 2010 Feb;10(2):273-9. [2]. Tim Eisen, et al. Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin. Curr Oncol Rep. 2014 Feb;16(2):370.

No Any Chemical & Physical Properties